Patrick Danaher
Research Subjects
Patrick Danaher has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- David T. Ting
Krantz Family Center for Cancer Research, Mass General Brigham Cancer Institute, Harvard Medical School, Boston, Massachusetts
12 shared publications - Alexandra S. Rojas
Mass General Cancer Center Harvard Medical School 02129 Charlestown MA USA
10 shared publications - Benjamin D. Greenbaum
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
10 shared publications - Bidish Patel
Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts
10 shared publications - Eunae You
Mass General Cancer Center Harvard Medical School 02129 Charlestown MA USA
10 shared publications - Ildiko E. Phillips
Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts
10 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Springer Nature in Scientific Reports
Breast cancer through the lens of whole transcriptome spatial imaging
Using the world’s first transcriptome-scale spatial imaging of a breast tumor, we assessed what could be learned about one patient’s disease. We cataloged heterogeneity across 3 morphological regions, 9 spatial domains, 37 cell types, and 1692 pathways. Then, employing a new algorithm for spatially stratified differential expression, we tested > 2 million hypotheses about cell types’ behavior across space. We measured how CD8 + T cells change upon entering the tumor, how cancer cells adapt to nutrient-poor microenvironments, how tumor glycolysis impacts nearby healthy cells, and how low-proliferation zones of the tumor are distinct. We found several instances of druggable biology: tumor heterogeneity and invasion programs suggested aggressiveness independent of traditional grading; PDCD1 expression and exhaustion limited T-cell activity; cancer cells exhibited angiogenic signaling but showed reduced proliferation in hypoxic regions; and a malignant subcluster up-regulated lipid metabolism. These findings demonstrate the insights obtainable through spatial profiling of individual tumors.
- 9 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessBreast cancer through the lens of whole transcriptome spatial imaging
Using the world’s first transcriptome-scale spatial imaging of a breast tumor, we assessed what could be learned about one patient’s disease. We cataloged heterogeneity across 3 morphological regions, 9 spatial domains, 37 cell types, and 1692 pathways. Then, employing a new algorithm for spatially stratified differential expression, we tested > 2 million hypotheses about cell types’ behavior across space. We measured how CD8 + T cells change upon entering the tumor, how cancer cells adapt to nutrient-poor microenvironments, how tumor glycolysis impacts nearby healthy cells, and how low-proliferation zones of the tumor are distinct. We found several instances of druggable biology: tumor heterogeneity and invasion programs suggested aggressiveness independent of traditional grading; PDCD1 expression and exhaustion limited T-cell activity; cancer cells exhibited angiogenic signaling but showed reduced proliferation in hypoxic regions; and a malignant subcluster up-regulated lipid metabolism. These findings demonstrate the insights obtainable through spatial profiling of individual tumors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S3. Key resources table
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S3. Key resources table
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S7 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Figure S1. LINE-1 ORF1p function in PDAC and other cell lines. Supplementary Figure S2. Titration of Dox concentration to rescue ORF1p expression and evaluation of micronuclei-mediated STING activation. Supplementary Figure S3. ORF1p knockdown sensitizes repeat RNA-induced IFN response. Supplementary Figure S4. ORF1p cellular localization and evaluation of RNA editing protein function. Supplementary Figure S5. EM-related gene expression and response to drugs upon ORF1 knockdown. Supplementary Figure S6. ORF1 knockdown in vivo suppresses tumor progression by altering the TME. Supplementary Figure S7. Analysis of single-cell spatial neighborhoods.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S7 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Figure S1. LINE-1 ORF1p function in PDAC and other cell lines. Supplementary Figure S2. Titration of Dox concentration to rescue ORF1p expression and evaluation of micronuclei-mediated STING activation. Supplementary Figure S3. ORF1p knockdown sensitizes repeat RNA-induced IFN response. Supplementary Figure S4. ORF1p cellular localization and evaluation of RNA editing protein function. Supplementary Figure S5. EM-related gene expression and response to drugs upon ORF1 knockdown. Supplementary Figure S6. ORF1 knockdown in vivo suppresses tumor progression by altering the TME. Supplementary Figure S7. Analysis of single-cell spatial neighborhoods.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S2. Classification of FOVs based on LINE-1 ORF1p expression.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S2. Classification of FOVs based on LINE-1 ORF1p expression.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S1. List of proteins localized in PBs.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Supplementary Table S1. List of proteins localized in PBs.
- Open Access
- 10 January 2026
- Published by Springer Nature in Genome Biology
- Vol. 27 (1)
Differential expression analysis for spatially correlated data using smiDE
Differential expression is a key application of imaging spatial transcriptomics, moving analysis beyond cell type localization to examining cell state resp
- 10 January 2026
- Published by Springer Nature in Genome Biology
- Vol. 27 (1)
Open AccessDifferential expression analysis for spatially correlated data using smiDE
Differential expression is a key application of imaging spatial transcriptomics, moving analysis beyond cell type localization to examining cell state resp
- Open Access
Breast cancer through the lens of whole transcriptome spatial imaging
Using the world’s first transcriptome-scale spatial imaging of a breast tumor, we assessed what could be learned about one patient’s disease. We cataloged heterogeneity across 3 morphological regions, 9 spatial domains, 37 cell types, and 1692 pathways. Then, employing a new algorithm for spatially stratified differential expression, we tested >2 million hypotheses about cell types’ behavior across space. We measured how CD8 + T cells change upon entering the tumor, how cancer cells adapt to nutrient-poor microenvironments, how tumor glycolysis impacts nearby healthy cells, and how low-proliferation zones of the tumor are distinct. We found several instances of druggable biology: the tumor’s heterogeneity and invasion programs suggested aggressiveness independent of traditional grading; PDCD1 expression and exhaustion limited T-cell activity; cancer cells engaged angiogenic signaling but struggled to proliferate in hypoxic regions; and a tumor subcluster up-regulated lipid metabolism. These findings demonstrate the insights obtainable through spatial profiling of individual tumors.
Open AccessBreast cancer through the lens of whole transcriptome spatial imaging
Using the world’s first transcriptome-scale spatial imaging of a breast tumor, we assessed what could be learned about one patient’s disease. We cataloged heterogeneity across 3 morphological regions, 9 spatial domains, 37 cell types, and 1692 pathways. Then, employing a new algorithm for spatially stratified differential expression, we tested >2 million hypotheses about cell types’ behavior across space. We measured how CD8 + T cells change upon entering the tumor, how cancer cells adapt to nutrient-poor microenvironments, how tumor glycolysis impacts nearby healthy cells, and how low-proliferation zones of the tumor are distinct. We found several instances of druggable biology: the tumor’s heterogeneity and invasion programs suggested aggressiveness independent of traditional grading; PDCD1 expression and exhaustion limited T-cell activity; cancer cells engaged angiogenic signaling but struggled to proliferate in hypoxic regions; and a tumor subcluster up-regulated lipid metabolism. These findings demonstrate the insights obtainable through spatial profiling of individual tumors.
- Open Access
- 20 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Using transcripts to refine image based cell segmentation with FastReseg
Spatial transcriptomics (ST) faces persistent challenges in cell segmentation accuracy, which can bias biological interpretations in a spatial-dependent way. FastReseg introduces a novel algorithm that refines inaccuracies in existing image-based segmentations using transcriptomic data, without radically redefining cell boundaries. By combining image-based information with 3D transcriptomic precision, FastReseg enhances segmentation accuracy. Its key innovation, a transcript scoring system based on log-likelihood ratios, facilitates the quick identification and correction of spatial doublets caused by cell proximity or overlap in 2D. FastReseg reduces circularity in boundary derivation, and addresses computational challenges with a modular workflow designed for large datasets. The algorithm’s modularity allows for seamless optimization and integration of advancements in segmentation technology. FastReseg provides a scalable, efficient solution to improve the quality and interpretability of ST data, ensuring compatibility with evolving segmentation methods and enabling more accurate biological insights.
- 20 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Open AccessUsing transcripts to refine image based cell segmentation with FastReseg
Spatial transcriptomics (ST) faces persistent challenges in cell segmentation accuracy, which can bias biological interpretations in a spatial-dependent way. FastReseg introduces a novel algorithm that refines inaccuracies in existing image-based segmentations using transcriptomic data, without radically redefining cell boundaries. By combining image-based information with 3D transcriptomic precision, FastReseg enhances segmentation accuracy. Its key innovation, a transcript scoring system based on log-likelihood ratios, facilitates the quick identification and correction of spatial doublets caused by cell proximity or overlap in 2D. FastReseg reduces circularity in boundary derivation, and addresses computational challenges with a modular workflow designed for large datasets. The algorithm’s modularity allows for seamless optimization and integration of advancements in segmentation technology. FastReseg provides a scalable, efficient solution to improve the quality and interpretability of ST data, ensuring compatibility with evolving segmentation methods and enabling more accurate biological insights.
- Open Access
Accounting for Spatial Correlation in Graphical Analysis of Spatial Transcriptomics Data
Co-expression analysis is key for understanding disease mechanisms and gene regulatory and functional relationships. In spatial transcriptomics, estimating gene correlation is challenging due to correlation among cells, which can lead to spurious associations that obscure true biological associations. To address this, we propose SpaceDecorr, a method that adjusts gene expression for technical artifacts and spatial dependencies by modeling each gene independently using a Negative Binomial Generalized Additive Model (NB-GAM) with spatial splines. Co-expression is then estimated from the Pearson residuals, yielding decorrelated expression values suitable for downstream analysis. This method targets cell-intrinsic coordination, rather than clustering genes by shared spatial patterns, and supports multi-sample analysis trough independent per-sample adjustment. Across simulations and real datasets, it consistently reduces false-positive correlations and improves the functional coherence of co-expression modules.
Open AccessAccounting for Spatial Correlation in Graphical Analysis of Spatial Transcriptomics Data
Co-expression analysis is key for understanding disease mechanisms and gene regulatory and functional relationships. In spatial transcriptomics, estimating gene correlation is challenging due to correlation among cells, which can lead to spurious associations that obscure true biological associations. To address this, we propose SpaceDecorr, a method that adjusts gene expression for technical artifacts and spatial dependencies by modeling each gene independently using a Negative Binomial Generalized Additive Model (NB-GAM) with spatial splines. Co-expression is then estimated from the Pearson residuals, yielding decorrelated expression values suitable for downstream analysis. This method targets cell-intrinsic coordination, rather than clustering genes by shared spatial patterns, and supports multi-sample analysis trough independent per-sample adjustment. Across simulations and real datasets, it consistently reduces false-positive correlations and improves the functional coherence of co-expression modules.
- Open Access
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Data from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Repeat element viral mimicry is a common feature in pancreatic ductal adenocarcinoma (PDAC) that requires mechanisms to manage this repeat “viral” load and attenuate innate immune responses. In this study, we show that the long interspersed nuclear element 1 (LINE-1) open reading frame 1 protein (ORF1p) in PDAC cells plays a role in shielding repeat RNAs from activating a pathogen recognition receptor–mediated antiviral response that is independent of retrotransposition. Suppression of ORF1p using short hairpin RNA induces innate immune responses through the double-stranded RNA (dsRNA) sensors RIG-I and MAVS. Low ORF1p PDAC cell lines have suppressed expression of pathogen recognition receptors demonstrating convergent mechanisms to suppress innate immune signaling. Localization of ORF1p in processing bodies with the dsRNA helicase MOV10 was found to be important for these antiviral responses. Loss of ORF1p resulted in significant growth reduction in tumorspheres and mouse xenografts with an enriched epithelial cell state, and high ORF1p expression was associated with worsened survival in a cohort of human patients with PDAC.Significance:This study uncovers PDAC-specific mechanisms that dampen immune responses to viral-repeat RNA via long interspersed nuclear element 1 ORF1p. Suppression of ORF1p activates antiviral responses, reducing tumor growth and epithelial–mesenchymal transition. High ORF1p expression correlates with poor prognosis, highlighting its potential as a therapeutic target for PDAC.
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Repeat element viral mimicry is a common feature in pancreatic ductal adenocarcinoma (PDAC) that requires mechanisms to manage this repeat “viral” load and attenuate innate immune responses. In this study, we show that the long interspersed nuclear element 1 (LINE-1) open reading frame 1 protein (ORF1p) in PDAC cells plays a role in shielding repeat RNAs from activating a pathogen recognition receptor–mediated antiviral response that is independent of retrotransposition. Suppression of ORF1p using short hairpin RNA induces innate immune responses through the double-stranded RNA (dsRNA) sensors RIG-I and MAVS. Low ORF1p PDAC cell lines have suppressed expression of pathogen recognition receptors demonstrating convergent mechanisms to suppress innate immune signaling. Localization of ORF1p in processing bodies with the dsRNA helicase MOV10 was found to be important for these antiviral responses. Loss of ORF1p resulted in significant growth reduction in tumorspheres and mouse xenografts with an enriched epithelial cell state, and high ORF1p expression was associated with worsened survival in a cohort of human patients with PDAC.Significance:This study uncovers PDAC-specific mechanisms that dampen immune responses to viral-repeat RNA via long interspersed nuclear element 1 ORF1p. Suppression of ORF1p activates antiviral responses, reducing tumor growth and epithelial–mesenchymal transition. High ORF1p expression correlates with poor prognosis, highlighting its potential as a therapeutic target for PDAC.